NOVOCART 3D Treatment Following Microfracture Failure

Therapuetic Areas:Orthopedics / Podiatry
Age Range:18 - 66
Start Date:November 30, 2018
End Date:December 2021
Contact:Jennifer Sisler, BSN, RN

Use our guide to learn which trials are right for you!

Safety and Efficacy of NOVOCART 3D in the Treatment of Articular Cartilage Defects Following Failure on Microfracture

This study is prospective single arm extension study of protocol AAG-G-H-1220. It is open
only to participants of AAG-G-H-1220 randomized to the Microfracture treatment group.

This study is an extension of protocol AAG-G-H-1220 wherein patients were randomized to
either NOVOCART 3D or Microfracture treatment groups. This prospective single arm extension
study is only open to participants of AAG-G-H-1220 who were randomized to Microfracture
treatment and who failed Microfracture treatment.

Inclusion Criteria:

- participated in study AAG-G-H-1220

- identified as a microfracture failure patient

- voluntary consent to participate in the study

Exclusion Criteria:

- other cartilage repair procedures performed on target knee

- other conditions that would interfere with healing or evaluating outcomes

- lesions requiring implants larger than 9cm2

- non-compliance with requirements in study AAG-G-H-1220
We found this trial at
281 W. Lane Ave
Columbus, Ohio 43210
(614) 292-6446
Principal Investigator: David Flanigan, MD
Phone: 614-293-2410
Ohio State University The Ohio State University’s main Columbus campus is one of America’s largest...
Columbus, OH
Click here to add this to my saved trials
North Logan, Utah 84341
Principal Investigator: Brad Larson, MD
Phone: 435-774-8512
North Logan, UT
Click here to add this to my saved trials